These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 29718996)

  • 1. Transcriptional repression by ApiAP2 factors is central to chronic toxoplasmosis.
    Radke JB; Worth D; Hong D; Huang S; Sullivan WJ; Wilson EH; White MW
    PLoS Pathog; 2018 May; 14(5):e1007035. PubMed ID: 29718996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposing Transcriptional Mechanisms Regulate
    Hong DP; Radke JB; White MW
    mSphere; 2017; 2(1):. PubMed ID: 28251183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of molecular and ultrastructural markers to evaluate stage conversion of Toxoplasma gondii in both the intermediate and definitive host.
    Ferguson DJ
    Int J Parasitol; 2004 Mar; 34(3):347-60. PubMed ID: 15003495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bradyzoite-specific surface antigen SRS9 plays a role in maintaining Toxoplasma gondii persistence in the brain and in host control of parasite replication in the intestine.
    Kim SK; Karasov A; Boothroyd JC
    Infect Immun; 2007 Apr; 75(4):1626-34. PubMed ID: 17261600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic and transcriptomic analyses of early and late-chronic Toxoplasma gondii infection shows novel and stage specific transcripts.
    Garfoot AL; Wilson GM; Coon JJ; Knoll LJ
    BMC Genomics; 2019 Nov; 20(1):859. PubMed ID: 31726967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ApiAP2 transcription factor restricts development of the Toxoplasma tissue cyst.
    Radke JB; Lucas O; De Silva EK; Ma Y; Sullivan WJ; Weiss LM; Llinas M; White MW
    Proc Natl Acad Sci U S A; 2013 Apr; 110(17):6871-6. PubMed ID: 23572590
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Bando H; Murata Y; Han Y; Sugi T; Fukuda Y; Bzik DJ; Fox BA; Kato K
    Front Cell Infect Microbiol; 2024; 14():1359888. PubMed ID: 38828265
    [No Abstract]   [Full Text] [Related]  

  • 8. Stage-specific expression of surface antigens by Toxoplasma gondii as a mechanism to facilitate parasite persistence.
    Kim SK; Boothroyd JC
    J Immunol; 2005 Jun; 174(12):8038-48. PubMed ID: 15944311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxoplasma gondii tachyzoite-bradyzoite interconversion.
    Lyons RE; McLeod R; Roberts CW
    Trends Parasitol; 2002 May; 18(5):198-201. PubMed ID: 11983592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The GRA17 Parasitophorous Vacuole Membrane Permeability Pore Contributes to Bradyzoite Viability.
    Paredes-Santos T; Wang Y; Waldman B; Lourido S; Saeij JP
    Front Cell Infect Microbiol; 2019; 9():321. PubMed ID: 31572690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxoplasma gondii metacaspase 2 is an important factor that influences bradyzoite formation in the Pru strain.
    Song X; Lin M; Li M; Yang X; Liu J; Liu Q
    Parasitol Res; 2020 Jul; 119(7):2287-2298. PubMed ID: 32468190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bradyzoite pseudokinase 1 is crucial for efficient oral infectivity of the Toxoplasma gondii tissue cyst.
    Buchholz KR; Bowyer PW; Boothroyd JC
    Eukaryot Cell; 2013 Mar; 12(3):399-410. PubMed ID: 23291621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAG2, a Toxoplasma gondii Bradyzoite Stage-Specific Cyst Matrix Protein.
    Tu V; Mayoral J; Yakubu RR; Tomita T; Sugi T; Han B; Williams T; Ma Y; Weiss LM
    mSphere; 2020 Feb; 5(1):. PubMed ID: 32075884
    [No Abstract]   [Full Text] [Related]  

  • 14. Toxoplasma gondii induces robust humoral immune response against cyst wall antigens in chronically infected animals and humans.
    Deshmukh AS; Gurupwar R; Mitra P; Aswale K; Shinde S; Chaudhari S
    Microb Pathog; 2021 Mar; 152():104643. PubMed ID: 33232762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolic acid induces differentiation of Toxoplasma gondii RH strain tachyzoites into bradyzoites and formation of cyst-like structure in vitro.
    Castro-Elizalde KN; Hernández-Contreras P; Ramírez-Flores CJ; González-Pozos S; Gómez de León CT; Mondragón-Castelán M; Mondragón-Flores R
    Parasitol Res; 2018 Feb; 117(2):547-563. PubMed ID: 29308550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxoplasma gondii AP2XII-2 Contributes to Proper Progression through S-Phase of the Cell Cycle.
    Srivastava S; White MW; Sullivan WJ
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32938695
    [No Abstract]   [Full Text] [Related]  

  • 17. A novel rhoptry protein in Toxoplasma gondii bradyzoites and merozoites.
    Schwarz JA; Fouts AE; Cummings CA; Ferguson DJ; Boothroyd JC
    Mol Biochem Parasitol; 2005 Dec; 144(2):159-66. PubMed ID: 16182390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of tissue cyst wall components by transcriptome analysis of in vivo and in vitro Toxoplasma gondii bradyzoites.
    Buchholz KR; Fritz HM; Chen X; Durbin-Johnson B; Rocke DM; Ferguson DJ; Conrad PA; Boothroyd JC
    Eukaryot Cell; 2011 Dec; 10(12):1637-47. PubMed ID: 22021236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Toxoplasma gondii cyst wall protein CST1 is critical for cyst wall integrity and promotes bradyzoite persistence.
    Tomita T; Bzik DJ; Ma YF; Fox BA; Markillie LM; Taylor RC; Kim K; Weiss LM
    PLoS Pathog; 2013; 9(12):e1003823. PubMed ID: 24385904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxoplasma gondii Cyclic AMP-Dependent Protein Kinase Subunit 3 Is Involved in the Switch from Tachyzoite to Bradyzoite Development.
    Sugi T; Ma YF; Tomita T; Murakoshi F; Eaton MS; Yakubu R; Han B; Tu V; Kato K; Kawazu S; Gupta N; Suvorova ES; White MW; Kim K; Weiss LM
    mBio; 2016 May; 7(3):. PubMed ID: 27247232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.